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Abstract
Background: To describe the characteristics of patients with tuberculosis (TB) requiring intensive care and to
identify the factors that predicts in-hospital mortality in a city of a developing country with intermediate-to-high TB
endemicity.
Methods: We conducted a retrospective, cohort study, between November 2005 and November 2007. The
patients with TB requiring intensive care were included. Predictors of mortality were assessed. The primary
outcome was the in-hospital mortality.
Results: During the study period, 67 patients with TB required intensive care. Of them, 62 (92.5%) had acute
respiratory failure and required mechanical ventilation. Forty-four (65.7%) patients died. Coinfection with human
immunodeficiency virus was present in 46 (68.7%) patients. Early intensive care unit admission and ventilator-
associated pneumonia were independently associated with the in-hospital mortality.
Conclusions: In this study we found a high mortality rate in TB patients requiring intensive care, especially in
those with an early ICU admission.
Background
Across the world tuberculosis (TB) remains an impor-
tant public health problem, especially in developing
countries. One third of the world’sp o p u l a t i o ni s
infected with Mycobacterium tuberculosis. Brazil is rank-
ing 15
th among the 22 high-burden countries that col-
lectively account for 80% of TB cases globally. The
incidence of TB was of 50 cases/100,000 population/yr
in 2006, and recently reached approximately 100 cases/
100,000 population in the city of Porto Alegre (southern
Brazil) [1]. Every year, almost 2 million people die of
TB, most of them in low- and middle-income countries.
The annual death rate from TB in Brazil was estimated
at 4.0/100,000 population/yr in 2006 [2].
Despite the availability of curative therapy, a large
proportion of patients with TB are being hospitalized. In-
hospital mortality rates remain high, particularly among
patients with TB requiring intensive care unit (ICU)
admission. These cases represent 1-3% of all patients
with TB [3]. Acute respiratory failure (ARF) caused by
TB necessitating mechanical ventilation (MV) has been
associated with mortality rates between 25.9% and 81%
[3-6]. Furthermore, such patients have a prognosis signif-
icantly worse than patients with nontuberculous pneu-
monia requiring MV [6].
Some studies reported a few factors that contribute
to mortality among critically ill patients with TB. Dis-
seminated disease, usually in the setting of human
immunodeficiency virus (HIV) infection, has been
recognized as an important predictor of death. Other
factors that can influence mortality rates are extensive
fibrocavitary disease and consolidations on chest radio-
graphs. Acute respiratory distress syndrome (ARDS),
sepsis and multiple organ failure (MOF) also carry a
very high mortality [5-7].
The purpose of this study was to describe the charac-
teristics of patients with TB requiring intensive care,
and to identify the factors that predict in-hospital
mortality in a city of a developing country with
intermediate-to-high TB endemicity.
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This study was conducted in Porto Alegre, Brazil, from
November 2005 through November 2007. Adult patients
with TB that were admitted to the ICU of the Clinics
Hospital of Porto Alegre (HCPA) were identified retro-
spectively. The HCPA is a general, tertiary care, univer-
sity-affiliated hospital with 750 beds (34 adult ICU beds)
and is a reference center for HIV in southern Brazil.
Porto Alegre is the city with the highest acquired immu-
nodeficiency syndrome (AIDS) incidence in Brazil (68.7
cases/100.000 population) [1]. In our hospital, in 2008
for example, we had approximately 29.000 hospitaliza-
tions per year, with 185 cases of pulmonary TB. In addi-
tion, the number of outpatient visits was 551.968, but
we do not have data on TB treatment, because our hos-
pital does not provide TB treatment for outpatients; in
Brazil, patients are treated in public outpatient health
care services. The medical records of patients were
reviewed, and predictors of mortality were assessed. The
protocol was submitted to the Ethics Committee at
HCPA and an approval was obtained. A waiver of con-
sent was approved and the investigators assigned a con-
fidentiality term.
Pulmonary TB is diagnosed according to the following
criteria established in the Brazilian Guidelines for
Tuberculosis [8]: 1) detection by a direct test (Ziehl-
Neelsen [ZN] method) - two positive samples; or 2)
detection by a direct test (ZN method) - one positive
sample and a positive culture result for Mycobacterium
tuberculosis (in Löwenstein-Jensen [LJ] medium); or 3)
detection by a direct test (ZN method) - one positive
sample and radiological findings compatible with TB; or
4) only a positive culture result for Mycobacterium
tuberculosis (in LJ medium); or 5) presence of clinical,
epidemiologic and radiographic findings compatible with
TB. The diagnosis of extra-pulmonary TB was based on
clinical and/or complementary tests according with the
location.
The following data were collected in a standardized
questionnaire: demographic data (sex, age, race, years of
schooling), smoking status, alcoholism, injection drug
use, clinical form of TB, symptoms at admission, meth-
ods of diagnostic, presence of comorbidities, prior TB
treatment, drug regimen, interval from hospital admis-
sion until initiation of treatment, delayed treatment (fail-
ure to initiate treatment within the first 24 hours after
admission to hospital), reasons for ICU admission, inter-
val from hospital admission until ICU admission (early
ICU [admitted directly or transferred to an ICU within
4 days of admission] and late ICU [admitted to an ICU
after 4 days of hospitalization]), ARF, ventilator-asso-
ciated pneumonia (VAP), Acute Physiologic and
Chronic Health Evaluation (APACHE) II scores,
presence of organ failures, ARDS, sepsis, septic shock,
length of hospital and ICU stay, length of mechanical
ventilation, laboratory investigations (white cell count,
hemoglobin, coagulation profile, liver and renal function
parameters, albumin, C-reactive protein, blood gas ana-
lysis), Glasgow coma score, urine output, use of vasoac-
tive drugs, hospitalization outcome (death or discharge),
and outcome after discharge (cure, dropout, death).
Data after discharge were obtained from SINAN
(National System of Information on Notifiable Diseases).
SINAN is a database from the Brazilian government
which stores information concerning all notifiable infec-
tious and contagious diseases. The duration of follow-up
period was one year.
A diagnosis of respiratory failure was made after the
determination of arterial oxygen pressure (PaO2) level of
less than 60 mmHg or arterial oxygen saturation (SaO2)
<9 0 % ,w i t ho rw i t h o u te l e v a t i o no fa r t e r i a lP C O 2.
ARDS was diagnosed based on the criteria defined in
the American-European consensus conference [9]. For
the diagnosis of organ failure, the criteria by Knaus [10]
were used. Multiple organ failure (MOF) was defined as
the failure of more than one organ. Ventilator-associated
pneumonia (VAP) was diagnosed based on the Ameri-
can Thoracic Society (ATS) criteria [11]. Anemia was
defined by hemoglobin levels < 13.5 g/dL for males and
< 12.0 g/dL for females. Hypoalbuminemia was consid-
ered when serum albumin levels were less than 3.5 g/dL.
Data analysis was performed using SPSS 14.0 (Statisti-
cal Package for the Social Sciences, Chicago, Illinois).
Data were presented as number of cases, mean ± stan-
dard deviation (SD), or median with interquartile range.
Categorical comparisons were performed by chi-square
test using Yates’s correction if indicated or by Fisher’s
exact test. Continuous variables were compared using
the t-test or Wilcoxon test. Variables with p < 0.20 in
the univariate analysis were analyzed in the multivariate
analyses. We have chosen this widespread adopted cut-
off because using a more traditional level (P < 0.05)
might fail to identify variables known to be important.
In addition, confusion variables can affect estimates
even when their level of significance does not reach
0.05. Kaplan-Meier survival curves were used to analyze
the survival of patients. Those factors significantly asso-
ciated with survival were further analyzed with the Cox
proportional hazard model (method forward) adjusted
by sex and age. Hazard ratio (HR) with 95% confidence
interval (CI) was used to report the results. A two-sided
p value < 0.05 was considered significant for all analyses.
Results
Between November 2005 and November 2007, 67
patients with TB required intensive care in our hospital.
Silva et al. BMC Infectious Diseases 2010, 10:54
http://www.biomedcentral.com/1471-2334/10/54
Page 2 of 7Of them, 62 (92.5%) had ARF and required MV. The
mean age of all patients was 43.2 ± 14.1 years and males
slightly outnumbered female patients (55.2% vs. 44.8%).
A history of previous TB was present in only 6 patients
(9%). Comorbid illnesses were identified in 58 (86.6%)
patients, with coinfection with HIV being the most com-
mon, present in 46 (68.7%) patients. The median CD4/
mm
3 count of these patients was 83 (range: 34 - 145),
and only 6 (13.0%) were receiving highly active anti-ret-
roviral therapy (HAART) at the time of hospitalization.
A history of alcoholism was present in 25 (37.3%)
patients and 20 (30%) were current smokers. Demo-
graphic and clinical characteristics did not differ
between the survivors and those that died (Table 1).
Twenty four (35.8%) patients had pulmonary disease
only, 21 (31.3%) had extrapulmonary disease only, and
22 (32.8%) had association of pulmonary and extrapul-
monary disease. The most common symptoms were
fever (44.8%), loss of weight (38.8%), cough (29.9%), and
neurologic ones (22.4%). Reticular infiltrate (35.8%) was
the most common radiographic finding, followed by
consolidation (23.9%). Forty six patients collected a spu-
tum sample, of whom 25 (54.3%) were sputum-smear
positive. Mycobacterial cultures were positive in 35
(52.2%) patients (13 bronchoalveolar lavage, 8 pleural
effusion, 3 spontaneous sputum, 3 bone marrow, 2 cere-
brospinal fluid, 2 blood, 1 induced sputum, 1 fine needle
aspiration of lymphonode, 1 ascitic fluid, 1 urine). In 9
(13.4%), TB diagnosis was based on clinical,
epidemiologic and radiographic findings. The median
interval from hospital admission until initiation of treat-
ment was 3 days (range: 1 - 8).
The primary cause for ICU admission was ARF in 42
(62.7%) patients. Other reasons were cardiopulmonary
arrest (10.4%), septic shock (7.5%), sepsis (6.0%), and
altered sensorium (6.0%). The mean APACHE II score
was 22.8 ± 6.8. Among ICU admissions, 18.9% and
81.1% were classified as early and late, respectively. At
ICU admission, most of the patients had anemia
(92.5%), with more than a half (52.2%) of these having
hemoglobin levels < 9 g/dL. The white blood cell
(WBC) count was less than 4000 mm
-3 in 14 patients
(20.9%) and more than 12000 mm
-3 in 13 patients
(19.4%). Hypoalbuminemia was present in 45 (67.2%)
patients. Mean serum albumin level was 2.2 ± 0.8 g/dL.
Although only 6.0% and 7.5% of patients had sepsis
and septic shock, respectively, most of the patients
developed sepsis (95.5%) and septic shock (83.6%) dur-
ing ICU stay. Only 9 (13.4%) patients developed ARDS.
During the course of ICU stay, 20 (29.9%) patients were
diagnosed with VAP, and over 80% of the patients had
MOF. Almost all patients (95.5%) developed acute renal
failure. Out of these patients, 29.9% required dialysis.
The median duration of hospitalization was 25 days
(range: 12.8 - 50), and the median ICU stay was 10 days
(range: 3 - 16.8).
Overall, 44 (65.7%) patients died, of whom 38 (56.7%)
died in ICU and 6 (8.9%) died after been transferred to
the ward. The Kaplan-Meier survival curve is showed in
Figure 1. Of the 23 patients who were discharged from
the hospital, 17 (73.9%) were cured, 2 (8.7%) abandoned
the treatment after 1 month, and 4 (17.4%) died after a
mean of 3.7 ± 2.5 months. As shown in Table 2, early
Table 1 Demographic and clinical characteristics of
hospitalized patients with TB requiring intensive care
Nonsurvivors
(n = 44)
Survivors
(n = 23)
p-value
Age, yr 44.2 ± 13.8 41.2 ± 14.8 0.414
Male sex 20 (45.5) 10 (43.5) 0.999
White race 34 (77.3) 14 (60.9) 0.259
< 8 yr of schooling 32 (82.1) 18 (85.7) 0.999
Current smoker 11 (26.8) 9 (45.0) 0.259
Presence of any
comorbidity
39 (88.6) 19 (82.6) 0.481
HIV 30 (71.4) 16 (72.7) 0.999
CD4 count 91 (83-229) 45.5 (25.5-116.8) 0.079
Alcoholism 13 (29.5) 12 (52.2) 0.121
Drug use 7 (15.9) 6 (26.1) 0.344
Diabetes 5 (11.4) 1 (4.3) 0.656
Corticosteroid use 6 (13.6) 0 0.087
Transplantation 3 (6.8) 0 0.546
Renal chronic disease 2 (4.5) 1 (4.3) 0.999
Hepatic disease 1 (2.3) 0 0.999
Desnutrition 1 (2.3) 3 (13.0) 0.113
Neoplasia 2 (4.5) 0 0.542
Data are presented as mean ± SD, n (%), or median (interquartile range). HIV:
human immunodeficiency virus.
Figure 1 Mortality among patients with tuberculosis requiring
intensive care: survival function at mean of covariates.
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0.004). Early ICU admission was also associated with
delayed diagnosis (p = 0.001) and acute renal failure (p
= 0.030). Miliary radiologic pattern and smear-positive
sputum were protective factors (p = 0.016 and 0.030,
respectively). Sixty three (94%) patients used rifampicin,
isoniazid and pirazynamid; 3 (4.5%) used streptomycin,
isoniazid and ethambutol; 1(1.5%) used rifampicin, iso-
niazid and ethambutol. Only 3 patients did not receive
rifampicin-based regimen because of hepatotoxicity.
Nonsurvivors used more rifampicin-based regimens
compared to survivors (p = 0.037). Neither hypoalbumi-
nemia (p = 0.111) nor hepatic dysfunction (p = 0.999)
h a de f f e c to nm o r t a l i t y .W eh a v ef o u n dn oa s s o c i a t i o n
between diagnosis of HIV and mortality (p = 0.999),
regardless of level of immunosuppression and use of
HAART. Although not statistically significant, a higher
mortality rate was found in patients with acute renal
failure (p = 0.133). VAP was more common in survivors
than in nonsurvivors (p = 0.041). The mean duration of
mechanical ventilation was not statistically different
between survivors and non-survivors (p = 0.228).
All predictors with p values ≤ 0.20 in the univariate
analysis were retained in the Cox-proportional hazard
model. The variables alcoholism, corticosteroid use, des-
nutrition, early ICU admission, miliary radiological pat-
tern, WBC > 12000 mm
-3, rifampicin-based regimens,
hepatotoxicity, septic shock, VAP and acute renal fail-
ure, adjusted by sex and age, were introduced into the
forward conditional Cox regression model, which
showed that early ICU admission (HR 4.93, 95% CI 2.44
- 9.97, p < 0.001) and VAP (HR 0.26-0.12, 95% CI 0.12 -
0.59, p = 0.001) were factors affecting the in-hospital
mortality rate (Figure 2).
Discussion
In this study, we aimed to evaluate, on a retrospective
basis, the risk factors associated with mortality among
patients with TB requiring intensive care. Overall, we
found a high in-hospital mortality rate (65.7%) in
patients with TB admitted to the ICU. Using multivari-
ate analysis, we identified early ICU admission as the
most important factor independently associated with
patient mortality. In addition, VAP was as a protective
factor for mortality.
Our results are consistent with previous epidemiologi-
cal data. Other studies have shown mortality rates up to
approximately 80% in TB patients with ARF requiring
MV [3-6,12]. In accordance with our findings, another
study demonstrated an ICU mortality rate of 61% and
an in-hospital mortality rate of 65.9% [5]. Early ICU
admission was independently associated with higher
mortality in multivariate analysis. This finding is consis-
tent with a previous study [13], and may be due to the
Table 2 Characteristics of disease presentation of hospitalized patients with TB requiring intensive care
Nonsurvivors (n = 44) Survivors (n = 23) p-value
APACHE II score 22.4 ± 6.9 23.4 ± 6.8 0.625
Early ICU admission 10 (100) 0 0.004
Presence of at least one symptom 35 (81.4) 21 (91.3) 0.474
Pulmonary TB 27 (61.4) 18 (78.3) 0.261
Isolated Pulmonary TB 16 (36.4) 8 (34.8) 0.999
Isolated Extrapulmonary TB 16 (36.4) 5 (21.7) 0.343
Pulmonary + Extrapulmonary TB 12 (27.3) 10 (43.5) 0.286
Cavitary disease 3 (6.8) 2 (8.7) 0.999
Milliary radiological pattern 2 (4.5) 6 (26.1) 0.016
Smear-positive sputum 10 (38.5) 15 (75.0) 0.030
Delayed diagnosis 14 (33.3) 7 (31.8) 0.999
WBC > 12000 mm
-3 11 (25.0) 2 (8.7) 0.192
Rifampicin-based regimens 44 (100) 20 (87.0) 0.037
Hepatotoxicity during hospitalization 5 (11.4) 6 (26.1) 0.167
Mechanical ventilation 41 (93.2) 21 (91.3) 0.999
Duration of mechanical ventilation, d 5 (2-15) 9.5 (3.75-21.3) 0.228
Sepsis 43 (97.7) 21 (93.3) 0.269
Septic shock 39 (88.6) 17 (73.9) 0.167
ARDS 5 (11.4) 4 (17.4) 0.481
Ventilator-associated pneumonia 9 (20.5) 11 (47.8) 0.041
Acute renal failure 17 (38.6) 4 (17.4) 0.133
Multiple organ failure 37 (84.1) 21 (91.3) 0.708
Data are presented as mean ± SD, n (%), or median (interquartile range). WBC: white blood cell. ARDS: acute respiratory distress syndrome.
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appears to be a plausible explanation as they have a
higher incidence of acute renal failure compared to
patients with a late ICU admission. Delayed treatment
w a sa l s om o r ef r e q u e n ti nt h i sg r o u p ,w h i c hc o n f i r m s
earlier observations [13,14]. Another factor that contri-
butes to the failure to initiate treatment within 24 hours
after admission is the less classic presentation. Indeed,
atypical features as sputum-smear negativity have been
suggested to be associated with delays in both diagnosis
and treatment and with mortality [13,15,16]. Our study
showed that sputum smear-positivity and a miliary
radiographic pattern were associated with a reduced risk
of death. Surprisingly, we found in univariate and multi-
variate analysis that VAP was a further protective factor
for mortality, in contrast with prior reports [4,17].
Although not statistically significant, the mean duration
of mechanical ventilation was longer in survivors com-
pared with nonsurvivors, which could explain the higher
incidence of VAP in the formers.
Our study has some methodological limitations. First,
the information was obtained retrospectively from chart
review and probably was not as complete and accurate
as when data collection is done prospectively. Certain
important factors that have been suggested as risk fac-
tors for mortality could not be included. Second, it must
be considered that this is a single center study with
small sample size. Despite these limitations, our results
provide important implications for similar demographic
areas and clinical settings.
In the present study, we observed a high incidence of
acute renal failure. In univariate analysis, we found that
acute renal failure was associated with death. Acute
renal failure is a common condition that affects many
ICU patients and is a well-recognized risk factor for
mortality [18,19]. However, the results reported across
studies in TB patients with acute renal failure are incon-
sistent. Although acute renal failure was identified as an
independent predictor of death in some studies [4,6,20],
others [3,12] did not find a significant impact of such
complication on the mortality of critically ill TB
patients.
Previous studies have shown a critical course in
patients with miliary TB and in HIV-infected patients
with TB [6,21]. However, we did not find an association
between a diagnosis of HIV and mortality in ICU
patients. In fact, mortality in patients with TB-HIV coin-
fection seems to be related to the patient’so v e r a l l
degree of immunosuppression [21]. In spite of the free
access to HAART in Brazil and the high level of immu-
nosuppression of our study population, only 13% of
patients were receiving HAART at the time of hospitali-
zation, which is probably related to poor or no adher-
ence to treatment. Even so, CD4/mm
3 count was not a
predictor of death in these patients. Furthermore, serum
albumin levels, reported by others as good predictors of
CD4/mm
3 lymphocyte counts in patients with TB [22],
were not associated with mortality in our study. The
lack of association between mortality and the HIV epi-
demic could be explained by the fact that our non-HIV
population had a high proportion of comorbidities and
were also too ill with high mortality rate.
We found that patients who used rifampicin-based
regimens had a higher mortality rate, even though not
confirmed in multivariate analysis. One hypothesis to
explain such observation is the possibility of multidrug-
resistant tuberculosis (MDR-TB). However, culture and
sensitivity test to antituberculosis drugs were not routi-
nely performed, so we could not estimate the prevalence
of MDR-TB in our sample. On the other hand,
Figure 2 Mortality among patients with tuberculosis requiring intensive care: survival functions for patterns of early intensive care
unit (ICU) admission and for ventilator-associated pneumonia (VAP).
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and subtherapeutic serum levels of rifampicin, especially
in HIV-positive population [24,25], have been reported
[26-28]. Drug interactions among antituberculosis drugs
and HAART are also important factors to be consid-
ered. In addition, low serum albumin levels could impair
drug absorption and was associated with low rifampicin
and ethambutol concentrations [29]. Whereas the great
majority of our study sample is composed by HIV-posi-
tive patients and hypoalbuminemia was a prevalent find-
ing, it is possible that some patients had low serum
rifampicin levels that went undetected.
To our knowledge this is the first study in Brazil that
described TB cases and their outcomes in patients
requiring intensive care. While effective treatment is
available on an outpatient basis, TB hospitalization and
mortality rates are substantially high in our center.
Patients with an early ICU admission have the highest
risk of death. Some factors were significant only in uni-
variate analysis, such as acute renal failure, miliary radi-
ological pattern, smear-positive sputum and rifampicin-
based regimens. The small sample size may have lacked
sufficient statistical power to reveal an association with
some of the factors. These results, if confirmed in a larger
prospective study, could contribute to a better under-
standing of characteristics associated with mortality.
Conclusions
In conclusion, in this study we found a high mortality
rate in TB patients requiring intensive care, especially in
those with an early ICU admission. Nevertheless, addi-
tional studies are necessary to confirm this data, taking
into account other possible risk factors for mortality like
MDR-TB and low serum levels of antituberculosis drugs,
potentially improving the care of critically ill TB patients.
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